🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers are evaluating the safety and effectiveness of a single adminis...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2019-10-30
Trial ID
NCT04176133
Treatments Being Tested
This is a Phase I/II study designed to evaluate the safety, tolerability, P...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2026-02-05
Trial ID
NCT07375758
Treatments Being Tested
The purpose of this study is to characterize the effects of 85 days treatme...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05-20
Trial ID
NCT02410499
Treatments Being Tested
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
To Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics o...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2024-04-10
Trial ID
NCT06344533
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled phase I...
Status
Completed
Location
Beijing Tong-Ren hospital
Start Date
2023-08-10
Trial ID
NCT05908032
The study evaluates the safety of different doses of a new medicine called ...
Status
Recruiting
Location
N America Res Inst - San Dimas
Start Date
2024-12-02
Trial ID
NCT06717698
Treatments Being Tested
This study tests whether an asthma medication called dupilumab can help peo...
Status
Recruiting
Location
Sir Charles Gairdner Hospital
Start Date
2026-01-29
Trial ID
NCT07309614
Treatments Being Tested
The purpose of this study is to determine if bempedoic acid (ETC-1002) 180m...
Status
Completed
Location
L-MARC Research Center
Start Date
2017-04-07
Trial ID
NCT03193047
Treatments Being Tested
The purpose of this clinical trial was to evaluate efficacy and safety of o...
Status
Completed
Location
Ascendis Pharma Investigational Site
Start Date
2023-03-03
Trial ID
NCT05598320
Treatments Being Tested